Method for detecting rhabdomyosarcoma using sample derived from body fluid

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8975021
APP PUB NO 20130203062A1
SERIAL NO

13639183

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a method for detecting rhabdomyosarcoma comprising evaluating expression of at least one kind of miRNA selected from the group consisting of hsa-miR-1, hsa-miR-133a, hsa-miR-133b, and hsa-miR-206 in a sample derived from body fluid.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION465 KAJII-CHO KAWARAMACHI-DORI HIROKOJI-AGARU KAMIGYO-KU KYOTO-SHI KYOTO 602-8566

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hosoi, Hajime Kyoto, JP 3 0
Miyachi, Mitsuru Kyoto, JP 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 10, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00